Correlation Between OKYO Pharma and RespireRx Pharmaceuticals

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both OKYO Pharma and RespireRx Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining OKYO Pharma and RespireRx Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between OKYO Pharma Ltd and RespireRx Pharmaceuticals, you can compare the effects of market volatilities on OKYO Pharma and RespireRx Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in OKYO Pharma with a short position of RespireRx Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of OKYO Pharma and RespireRx Pharmaceuticals.

Diversification Opportunities for OKYO Pharma and RespireRx Pharmaceuticals

0.0
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between OKYO and RespireRx is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding OKYO Pharma Ltd and RespireRx Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on RespireRx Pharmaceuticals and OKYO Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on OKYO Pharma Ltd are associated (or correlated) with RespireRx Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of RespireRx Pharmaceuticals has no effect on the direction of OKYO Pharma i.e., OKYO Pharma and RespireRx Pharmaceuticals go up and down completely randomly.

Pair Corralation between OKYO Pharma and RespireRx Pharmaceuticals

If you would invest  106.00  in OKYO Pharma Ltd on December 20, 2024 and sell it today you would earn a total of  26.00  from holding OKYO Pharma Ltd or generate 24.53% return on investment over 90 days.
Time Period3 Months [change]
DirectionFlat 
StrengthInsignificant
Accuracy0.0%
ValuesDaily Returns

OKYO Pharma Ltd  vs.  RespireRx Pharmaceuticals

 Performance 
       Timeline  
OKYO Pharma 

Risk-Adjusted Performance

OK

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in OKYO Pharma Ltd are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. In spite of very fragile basic indicators, OKYO Pharma displayed solid returns over the last few months and may actually be approaching a breakup point.
RespireRx Pharmaceuticals 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days RespireRx Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fairly strong basic indicators, RespireRx Pharmaceuticals is not utilizing all of its potentials. The current stock price confusion, may contribute to short-horizon losses for the traders.

OKYO Pharma and RespireRx Pharmaceuticals Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with OKYO Pharma and RespireRx Pharmaceuticals

The main advantage of trading using opposite OKYO Pharma and RespireRx Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if OKYO Pharma position performs unexpectedly, RespireRx Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in RespireRx Pharmaceuticals will offset losses from the drop in RespireRx Pharmaceuticals' long position.
The idea behind OKYO Pharma Ltd and RespireRx Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.

Other Complementary Tools

Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Money Managers
Screen money managers from public funds and ETFs managed around the world
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges